Last reviewed · How we verify

NCT06592755

Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for PTC

Recruiting now Last updated 1 October 2024
What this trial tests

trial testing single-incision, gasless endoscopic total thyroidectomy with central compartment neck dissection in Papillary Thyroid Carcinoma in 120 participants. Currently enrolling.

Timeline
20 September 2024
Primary endpoint
30 September 2024
30 September 2024

Quick facts

Lead sponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment120
Start date20 September 2024
Primary completion30 September 2024
Estimated completion30 September 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Who can join

Adults 18 to 70, any sex, with Papillary Thyroid Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Historically, performing a contralateral thyroid lobectomy and lymph node dissection via the subclavian approach was considered challenging. This study aimed to evaluate the safety and feasibility of single-incision gasless endoscopic total thyroidectomy and central compartment neck dissection via the subclavian approach (SCA) in comparison to conventional open surgery for the treatment of papillary thyroid carcinoma (PTC) retrospectively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Papillary Thyroid Carcinoma

Currently open trials in the same condition.

Other Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06592755.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing